With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...

An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Starting this spring, the Respiratory Syncytial Virus (RSV) vaccine will be available to adults aged 60 years and older residing in congregate living facilities, such as long-term care homes and ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Early data suggests that the respiratory syncytial virus (RSV) vaccination programme is significantly reducing hospital admissions among ...

The United Kingdom’s Health Security Agency (HSA) yesterday published it first annual report on infectious disease trends, ...

Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

The respiratory syncytial virus (RSV) infects cells along the human respiratory tract, from the nose to the lungs. Each year ...

The Triad's three main healthcare systems separately announced Wednesday they will lift at 7 a.m. Thursday their respiratory ...

Provincial health officer Dr. Bonnie Henry said B.C.'s COVID-19 hospitalizations have hit the lowest level since 2020, with ...